Current Clinical Psychopharmacology in Borderline Personality Disorder

CONCLUSIONS: No medication is currently approved for BPD, and clinicians should carefully assess the benefits and risks of drug treatment. Further studies are needed to identify specific personalized treatment strategies, also considering the clinical heterogeneity and possible comorbidities of BPD.PMID:34151763 | DOI:10.2174/1570159X19666210610092958

Source: Current Neuropharmacology - June 21, 2021 Category: Drugs & Pharmacology Authors: Antonio Del Casale Luca Bonanni Paride Bargagna Francesco Novelli Federica Fiasch è Marco Paolini Francesca Forcina Gaia Anibaldi Francesca Natalia Cortese Alessia Lannuccelli Barbara Adriani Roberto Brugnoli Paolo Girardi Joel Paris Maurizio Pompili Source Type: research